Annual CFO
-$67.39 M
-$18.28 M-37.23%
31 December 2023
Summary:
Terns Pharmaceuticals annual cash flow from operations is currently -$67.39 million, with the most recent change of -$18.28 million (-37.23%) on 31 December 2023. During the last 3 years, it has fallen by -$37.58 million (-126.07%). TERN annual CFO is now -272.92% below its all-time high of -$18.07 million, reached on 31 December 2018.TERN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$16.45 M
-$276.00 K-1.71%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly cash flow from operations is currently -$16.45 million, with the most recent change of -$276.00 thousand (-1.71%) on 30 September 2024. Over the past year, it has increased by +$4.24 million (+20.50%). TERN quarterly CFO is now -160.65% below its all-time high of -$6.31 million, reached on 30 September 2020.TERN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$74.75 M
+$4.24 M+5.37%
30 September 2024
Summary:
Terns Pharmaceuticals TTM cash flow from operations is currently -$74.75 million, with the most recent change of +$4.24 million (+5.37%) on 30 September 2024. Over the past year, it has dropped by -$15.46 million (-26.08%). TERN TTM CFO is now -925.77% below its all-time high of -$7.29 million, reached on 31 March 2020.TERN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.2% | +20.5% | -26.1% |
| 3 y3 years | -126.1% | -103.6% | -93.9% |
| 5 y5 years | -272.9% | - | - |
TERN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -126.1% | at low | -103.6% | +27.8% | -93.9% | +5.4% |
| 5 y | 5 years | -272.9% | at low | -160.7% | +27.8% | -925.8% | +5.4% |
| alltime | all time | -272.9% | at low | -160.7% | +27.8% | -925.8% | +5.4% |
Terns Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.45 M(+1.7%) | -$74.75 M(-5.4%) |
| June 2024 | - | -$16.18 M(-29.0%) | -$78.99 M(+4.2%) |
| Mar 2024 | - | -$22.80 M(+18.0%) | -$75.81 M(+12.5%) |
| Dec 2023 | -$67.39 M(+37.2%) | -$19.32 M(-6.7%) | -$67.39 M(+13.7%) |
| Sept 2023 | - | -$20.70 M(+59.3%) | -$59.28 M(+14.0%) |
| June 2023 | - | -$12.99 M(-9.7%) | -$52.02 M(+3.6%) |
| Mar 2023 | - | -$14.38 M(+28.3%) | -$50.19 M(+2.2%) |
| Dec 2022 | -$49.11 M | -$11.21 M(-16.6%) | -$49.11 M(+1.1%) |
| Sept 2022 | - | -$13.44 M(+20.4%) | -$48.57 M(+12.4%) |
| June 2022 | - | -$11.16 M(-16.1%) | -$43.21 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.30 M(+24.7%) | -$40.81 M(-2.4%) |
| Dec 2021 | -$41.83 M(+40.3%) | -$10.67 M(+32.0%) | -$41.83 M(+8.5%) |
| Sept 2021 | - | -$8.08 M(-7.7%) | -$38.55 M(+4.8%) |
| June 2021 | - | -$8.76 M(-38.8%) | -$36.78 M(-0.2%) |
| Mar 2021 | - | -$14.32 M(+93.8%) | -$36.84 M(+23.6%) |
| Dec 2020 | -$29.81 M(-55.0%) | -$7.39 M(+17.0%) | -$29.81 M(+32.9%) |
| Sept 2020 | - | -$6.31 M(-28.4%) | -$22.42 M(+39.2%) |
| June 2020 | - | -$8.82 M(+21.1%) | -$16.11 M(+121.1%) |
| Mar 2020 | - | -$7.29 M | -$7.29 M |
| Dec 2019 | -$66.22 M(+266.5%) | - | - |
| Dec 2018 | -$18.07 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual CFO year-on-year change?
- What is Terns Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly CFO year-on-year change?
- What is Terns Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM CFO year-on-year change?
What is Terns Pharmaceuticals annual cash flow from operations?
The current annual CFO of TERN is -$67.39 M
What is the all time high annual CFO for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual cash flow from operations is -$18.07 M
What is Terns Pharmaceuticals annual CFO year-on-year change?
Over the past year, TERN annual cash flow from operations has changed by -$18.28 M (-37.23%)
What is Terns Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of TERN is -$16.45 M
What is the all time high quarterly CFO for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly cash flow from operations is -$6.31 M
What is Terns Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, TERN quarterly cash flow from operations has changed by +$4.24 M (+20.50%)
What is Terns Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of TERN is -$74.75 M
What is the all time high TTM CFO for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM cash flow from operations is -$7.29 M
What is Terns Pharmaceuticals TTM CFO year-on-year change?
Over the past year, TERN TTM cash flow from operations has changed by -$15.46 M (-26.08%)